GW Pharmaceuticals PLC (GWPH)

84.52 -0.48  -0.56% NASDAQ Apr 2, 20:00 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
05/06/2020 16:30 EDT Misc GW Pharmaceuticals PLC First Quarter Earnings Conference Call in 2020
05/06/2020 Earnings GW Pharmaceuticals PLC First Quarter Earnings in 2020 Release
02/27/2020 Misc GW Pharmaceuticals PLC Annual Report for 2019
02/25/2020 16:30 EST Misc GW Pharmaceuticals PLC Fourth Quarter Earnings Conference Call for 2019
02/25/2020 Earnings GW Pharmaceuticals PLC Fourth Quarter Earnings in 2019 Release
11/05/2019 16:30 EST Misc GW Pharmaceuticals PLC Third Quarter Earnings Conference Call for 2019
11/05/2019 Earnings GW Pharmaceuticals PLC Third Quarter Earnings in 2019 Release
08/06/2019 16:30 EDT Misc GW Pharmaceuticals PLC Second Quarter Earnings Conference Call in 2019
08/06/2019 Earnings GW Pharmaceuticals PLC Second Quarter Earnings in 2019 Release
06/13/2019 10:00 BST Misc GW Pharmaceuticals PLC Annual General Meeting in 2018
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.gwpharm.com
  • Investor Relations URL: http://ir.gwpharm.com/
  • HQ State/Province: N/A
  • Sector: Healthcare
  • Industry: Drug Manufacturers - General
  • Equity Style: Mid Cap/Value
  • Next Earnings Release: May. 06, 2020
  • Last Earnings Release: Feb. 25, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: GW Pharmaceuticals PLC is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. The company's lead product candidate is Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol used for the treatment of a number of rare childhood-onset epilepsy disorders. The company also develops and markets Sativex, an oromucosal spray for the treatment of spasticity due to multiple sclerosis. Geographically its presence can be seen across the region of UK, Europe, US, Canada, and others.

Top Fund Holders

Symbol Name Weighting
HMMJ.TO Horizons Marijuana Life Sciences ETF 11.42%
MJ ETFMG Alternative Harvest ETF 8.61%
YOLO AdvisorShares Pure Cannabis ETF 7.10%
FRBRX Franklin Biotechnology Discovery R6 3.47%
BCSVX Brown Capital Mgmt Intl Sm Co Inv 2.32%
AHSCX Alger Health Sciences C 2.29%
GLO Clough Global Opportunities 1.96%
GLQ Clough Global Equity 1.91%
ETCHX Eventide Healthcare & Life Sciences C 1.86%
PPH VanEck Vectors Pharmaceutical ETF 1.37%
FSSRX Franklin Small Cap Growth R 1.19%
WSCAX Wanger International 1.06%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.